SEC Form 4 · accession 0001171000-17-000045
Nexvet Biopharma plc · NVET
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Ashraf Hanna
Director
Period of report
Jun 30, 2017
Accepted (ET)
Jul 5, 2017 · 12:28 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001618561
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares | Jun 30, 2017 | M | 500 | $0.125 | A | 12,420 | D | |
| Ordinary Shares | Jul 1, 2017 | M | 3,600 | $0.125 | A | 16,020 | D | |
| Ordinary Shares | holding | — | — | — | 1,500 | I | Ashraf E. Hanna Living Family Trust U/A 8/20/15 |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Share Units | $0.125 | Jun 30, 2017 | M | 500 | D | Jun 30, 2017 | Jul 1, 2019 | Ordinary Shares | 500 | 0 | D |
| Restricted Share Units | $0.125 | Jul 1, 2017 | M | 3,600 | D | Jul 1, 2017 | Jul 1, 2021 | Ordinary Shares | 3,600 | 0 | D |